B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PRMT5

MOLECULAR TARGET

protein arginine methyltransferase 5

UniProt: O14744NCBI Gene: 104195 compounds

PRMT5 (protein arginine methyltransferase 5) is targeted by 5 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PRMT5

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1sinefungin3.7441
2stilbamidine2.8917
3s adenosylhomocysteine1.393
4same0.691
5s adenosylmethionine0.691

About PRMT5 as a Drug Target

PRMT5 (protein arginine methyltransferase 5) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 5 compounds with documented PRMT5 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PRMT5 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.